Does digitalis work in chronic heart failure? The end of a 200-year-old controversy

Milton Packer

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Controlled trials using modern methods of assessment in well-defined groups of patients have now convincingly demonstrated that digitalis is an effective and well-tolerated drug in patients with chronic heart failure who have left ventricular systolic dysfunction. These encouraging findings concerning digitalis, however, should not be construed to suggest that the drug should be used alone in the treatment of heart failure. Digitalis cannot adequately control the fluid retention seen in most patients with chronic heart failure; diuretics should be added to maintain sodium balance. Digitalis has not been shown to prolong life in chronic heart failure; converting-enzyme inhibitors should be added to reduce morbidity and mortality. All three drugs should be used together in the management of patients with this disorder.

Original languageEnglish (US)
Pages (from-to)743-746
Number of pages4
JournalCardiovascular Drugs and Therapy
Volume2
Issue number6
DOIs
StatePublished - Jan 1989

Fingerprint

Digitalis
Heart Failure
Pharmaceutical Preparations
Left Ventricular Dysfunction
Enzyme Inhibitors
Treatment Failure
Diuretics
Sodium
Morbidity
Mortality

Keywords

  • congestive heart failure
  • digitalis
  • diuretics
  • left ventricular systolic failure

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Does digitalis work in chronic heart failure? The end of a 200-year-old controversy. / Packer, Milton.

In: Cardiovascular Drugs and Therapy, Vol. 2, No. 6, 01.1989, p. 743-746.

Research output: Contribution to journalArticle

@article{58a3299d94a14055bf431046e4710ea4,
title = "Does digitalis work in chronic heart failure? The end of a 200-year-old controversy",
abstract = "Controlled trials using modern methods of assessment in well-defined groups of patients have now convincingly demonstrated that digitalis is an effective and well-tolerated drug in patients with chronic heart failure who have left ventricular systolic dysfunction. These encouraging findings concerning digitalis, however, should not be construed to suggest that the drug should be used alone in the treatment of heart failure. Digitalis cannot adequately control the fluid retention seen in most patients with chronic heart failure; diuretics should be added to maintain sodium balance. Digitalis has not been shown to prolong life in chronic heart failure; converting-enzyme inhibitors should be added to reduce morbidity and mortality. All three drugs should be used together in the management of patients with this disorder.",
keywords = "congestive heart failure, digitalis, diuretics, left ventricular systolic failure",
author = "Milton Packer",
year = "1989",
month = "1",
doi = "10.1007/BF00133202",
language = "English (US)",
volume = "2",
pages = "743--746",
journal = "Cardiovascular Drugs and Therapy",
issn = "0920-3206",
publisher = "Kluwer Academic Publishers",
number = "6",

}

TY - JOUR

T1 - Does digitalis work in chronic heart failure? The end of a 200-year-old controversy

AU - Packer, Milton

PY - 1989/1

Y1 - 1989/1

N2 - Controlled trials using modern methods of assessment in well-defined groups of patients have now convincingly demonstrated that digitalis is an effective and well-tolerated drug in patients with chronic heart failure who have left ventricular systolic dysfunction. These encouraging findings concerning digitalis, however, should not be construed to suggest that the drug should be used alone in the treatment of heart failure. Digitalis cannot adequately control the fluid retention seen in most patients with chronic heart failure; diuretics should be added to maintain sodium balance. Digitalis has not been shown to prolong life in chronic heart failure; converting-enzyme inhibitors should be added to reduce morbidity and mortality. All three drugs should be used together in the management of patients with this disorder.

AB - Controlled trials using modern methods of assessment in well-defined groups of patients have now convincingly demonstrated that digitalis is an effective and well-tolerated drug in patients with chronic heart failure who have left ventricular systolic dysfunction. These encouraging findings concerning digitalis, however, should not be construed to suggest that the drug should be used alone in the treatment of heart failure. Digitalis cannot adequately control the fluid retention seen in most patients with chronic heart failure; diuretics should be added to maintain sodium balance. Digitalis has not been shown to prolong life in chronic heart failure; converting-enzyme inhibitors should be added to reduce morbidity and mortality. All three drugs should be used together in the management of patients with this disorder.

KW - congestive heart failure

KW - digitalis

KW - diuretics

KW - left ventricular systolic failure

UR - http://www.scopus.com/inward/record.url?scp=0024364141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024364141&partnerID=8YFLogxK

U2 - 10.1007/BF00133202

DO - 10.1007/BF00133202

M3 - Article

VL - 2

SP - 743

EP - 746

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

SN - 0920-3206

IS - 6

ER -